MedPath

江苏欣力元生物制药有限公司

Ownership
-
Established
2022-09-23
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Oseltamivir Phosphate Granules

Product Name
磷酸奥司他韦颗粒
Approval Number
国药准字H20234694
Approval Date
Dec 26, 2023
NMPA

丹参口服液

Approval Number
国药准字Z20054193
Approval Date
Jul 5, 2021
NMPA

丹参口服液

Approval Number
国药准字Z20054140
Approval Date
Jul 5, 2021
NMPA

银黄口服液

Approval Number
国药准字Z20054139
Approval Date
May 26, 2021
NMPA

小儿咳喘灵口服液

Approval Number
国药准字Z32021212
Approval Date
Aug 31, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.